Nan Fung Group Holdings Ltd Top Holdings and 13F Report (2026) About Nan Fung Group Holdings LtdInvestment ActivityNan Fung Group Holdings Ltd has $121.26 million in total holdings as of March 31, 2026.Nan Fung Group Holdings Ltd owns shares of 24 different stocks, but just 9 companies or ETFs make up 80% of its holdings.Approximately 10.28% of the portfolio was purchased this quarter.About 9.93% of the portfolio was sold this quarter.This quarter, Nan Fung Group Holdings Ltd has purchased 27 new stocks and bought additional shares in 1 stock.Nan Fung Group Holdings Ltd sold shares of 4 stocks and completely divested from 5 stocks this quarter.Largest Holdings EVOMMUNE INC $33,129,326MAPLIGHT THERAPEUTICS INC $19,745,573LB PHARMACEUTICALS INC $15,552,002Oculis $9,326,310Incyte $5,058,197 Largest New Holdings this Quarter 15102K100 - Celcuity $3,230,162 Holding457669307 - Insmed $1,075,962 Holding Largest Purchases this Quarter LB PHARMACEUTICALS INC 330,657 shares (about $8.15M)Celcuity 28,300 shares (about $3.23M)Insmed 6,580 shares (about $1.08M) Largest Sales this Quarter Oculis 163,957 shares (about $4.36M)Madrigal Pharmaceuticals 6,200 shares (about $3.25M)Incyte 5,280 shares (about $496.95K)BOLT BIOTHERAPEUTICS INC 29,097 shares (about $117.55K) Sector Allocation Over TimeMap of 500 Largest Holdings ofNan Fung Group Holdings Ltd Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorEVOMMUNE INC$33,129,3260.0%1,441,03227.3%COM SHSMAPLIGHT THERAPEUTICS INC$19,745,5730.0%971,25316.3%COMLB PHARMACEUTICALS INC$15,552,002$8,154,002 â–²110.2%630,65712.8%COM SHSOCSOculis$9,326,310$4,359,617 â–¼-31.9%350,7457.7%MedicalINCYIncyte$5,058,197$496,954 â–¼-8.9%53,7424.2%MedicalBEONE MEDICINES LTD$4,668,9620.0%15,7223.9%SPONSORED ADSRYTMRhythm Pharmaceuticals$4,271,9660.0%49,1203.5%MedicalCELCCelcuity$3,230,162$3,230,162 â–²New Holding28,3002.7%MedicalASNDAscendis Pharma A/S$3,110,7280.0%13,6002.6%MedicalPCORProcore Technologies$3,038,0430.0%53,2992.5%Computer and TechnologyMDGLMadrigal Pharmaceuticals$2,969,122$3,245,514 â–¼-52.2%5,6722.4%MedicalKYMRKymera Therapeutics$2,571,5790.0%30,8752.1%MedicalACADACADIA Pharmaceuticals$2,292,4240.0%102,9841.9%MedicalCYBIN INC$2,208,0000.0%460,0001.8%COM NEWARGXargenex$2,044,7000.0%2,8001.7%MedicalRVMDRevolution Medicines$1,872,3540.0%19,2531.5%MedicalRXRXRecursion Pharmaceuticals$1,827,5310.0%595,2871.5%MedicalINSMInsmed$1,075,962$1,075,962 â–²New Holding6,5800.9%MedicalISHARES ETHEREUM TR$800,1910.0%50,5490.7%SHSHRMYHarmony Biosciences$757,6420.0%27,0490.6%MedicalTRDAEntrada Therapeutics$619,4150.0%49,0820.5%MedicalISHARES BITCOIN TRUST ETF$613,4910.0%15,9680.5%SHS BEN INTRANIRani Therapeutics$362,6860.0%493,5840.3%MedicalBOLT BIOTHERAPEUTICS INC$118,170$117,552 â–¼-49.9%29,2500.1%COM NEWLABStandard BioTools$0$2,410,469 â–¼-100.0%00.0%MedicalREPLReplimune Group$0$619,349 â–¼-100.0%00.0%MedicalBCYCBicycle Therapeutics$0$488,116 â–¼-100.0%00.0%MedicalROCKET LAB CORP$0$266,762 â–¼-100.0%00.0%COMBOLT PROJS HLDGS INC$0$32,437 â–¼-100.0%00.0%COM NEWShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
